Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Thioglycolic Acid | HCID 1133 | — |
| Reactant | Lithium hydroxide, monohydrate | HCID 168937 | — |
| Reactant | HCID 66616133 | HCID 66616133 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | HCID 66616094 | HCID 66616094 | 71% |
Reaction Steps
To a solution of (S)—N-(1-(4-(3,3-dimethyl-2-oxoindolin-1-yl)piperidin-1-yl)-1-oxo-4-phenylbutan-2-yl)-N-methyl-2-nitrobenzenesulfonamide (3.30 g, with triphenylphosphineoxide as impurity, EXAMPLE 73, Step 2) in dimethyl formamide (10 mL) were added mercaptoacetic acid (491 mg, 5.33 mmol) and lithium hydroxide monohydrate (447 mg, 10.7 mmol) at room temperature. After stirring for 16 h, the mixture was diluted with ethyl acetate and saturated sodium hydrogen carbonate aqueous solution. The organic layer was washed with saturated sodium hydrogen carbonate aqueous solution and brine, dried over sodium sulfate and concentrated in vacuo. The residue was diluted with dichloromethane (10 mL) and to the solution was added hydrogen chloride in methanol. Then the mixture was concentrated. The residue was diluted with methanol, and mixed with strong cation exchange gel (BondeSil(registered trademark) SCX, 40 g, Varian Inc.). The gel was filtered and washed with 1 mol/L ammonia in methanol, and the solution was concentrated to give the title compound (636 mg, 71%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08697877B2 |
|---|
| Source dataset | uspto-grants-2014_04 |
|---|
| ORD ID | ord-442c6997ebfe4e62ad9366f59e7643de |
|---|
| Source note | uspto-grants-2014_04 |
|---|